The June 2026 edition of the Givens Health Venture Report explores a defining moment of structural friction and capital opportunity within the Texas innovation ecosystem. While the Hill County’s historic data center construction moratorium and the subsequent $100 million developer lawsuit signal intense local resistance to Big Tech’s rapid grid consumption, the state's healthcare sector is emerging as a resilient, highly capitalized safe haven.

This evolution is driven by a monumental $103 million state injection from CPRIT, alongside critical institutional milestones like UT Austin’s dual appointments in clinical AI and venture entrepreneurship. As capital aggressively shifts toward deep clinical quality, this month's report analyzes the high-conviction, early-stage deployments defining the region, epitomized by Secretome Therapeutics’ landmark $30 million Series A.

This inaugural issue of The Givens Health Venture Report analyzes a landmark month for the "Texas Triangle," anchored by the Michael & Susan Dell Foundation’s historic $1 billion infrastructure gift and Eli Lilly’s strategic acquisition of Houston-based CrossBridge Bio.

It provides actionable intelligence on the state's rapid pivot toward AI-native clinical solutions and highlights the critical deal flow emerging from local catalysts as Texas cements its position as a global engine for medical innovation and venture liquidity.